Survival in advanced breast cancer Combination chemotherapy improves outlook

BMJ 1994; 308 doi: 10.1136/bmj.308.6936.1103a (Published 23 April 1994)
Cite this as: BMJ 1994;308:1103.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. L A Price
  1. London W1N 1DL
  2. Royal Marsden Hospital, Sutton, Surrey SM2 5PT.

    EDITOR, - I E Smith's editorial on palliative chemotherapy for advanced non-small cell lung cancer contains a worrying error of fact.1 The statement that an average improvement in survival of around three months after chemotherapy is more than has been shown for chemotherapy in advanced breast cancer is not …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL